Monto, Almaida .
HRN: 11-70-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
CEFUROXIME 500MG (TAB)
11/21/2023
11/28/2023
PO
500mg
BID
Rmle
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes